Taking the Longer View of COVID-19
- PMID: 32304334
- PMCID: PMC7264596
- DOI: 10.1634/theoncologist.2020-0313
Taking the Longer View of COVID-19
Abstract
What are the prospects for dealing with COVID‐19 more effectively in the future? This editorial addresses the question from the perspective of long‐term control of coronavirus infection.
Conflict of interest statement
Comment on
-
RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20. Int J Antimicrob Agents. 2020. Retraction in: Int J Antimicrob Agents. 2025 Jan;65(1):107416. doi: 10.1016/j.ijantimicag.2024.107416. PMID: 32205204 Free PMC article. Retracted. Clinical Trial.
References
-
- Akst J. COVID‐19 vaccine frontrunners. The Scientist. April 7, 2020. Available at https://www.the‐scientist.com/news‐opinion/covid‐19‐vaccine‐frontrunners.... Accessed April 8, 2020.
-
- Lurie N, Saville M, Hatchett R et al. Developing COVID‐19 vaccines at pandemic speed. New Engl J 2020. [Epub ahead of print]. - PubMed
-
- World Health Organization . Draft landscape of COVID‐19 candidate vaccines—March 20, 2020. Available at https://www.who.int/blueprint/priority‐diseases/key‐action/novel‐coronav.... Accessed March 20, 2020.
-
- Voss A. International Society of Antimicrobial Chemotherapy Statement on IJAA paper (Gautret P et. Al. PMID 32205204). Available at https://www.isac.world/news‐and‐publications/official‐isac‐statement. Accessed April 3, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
